APVO Annual D&A
$567.00 K
-$334.00 K-37.07%
31 December 2023
Summary:
As of January 23, 2025, APVO annual depreciation & amortization is $567.00 thousand, with the most recent change of -$334.00 thousand (-37.07%) on December 31, 2023. During the last 3 years, it has fallen by -$839.00 thousand (-59.67%). APVO annual D&A is now -83.14% below its all-time high of $3.36 million, reached on December 31, 2016.APVO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APVO Quarterly D&A
$84.00 K
-$7000.00-7.69%
30 September 2024
Summary:
As of January 23, 2025, APVO quarterly depreciation & amortization is $84.00 thousand, with the most recent change of -$7000.00 (-7.69%) on September 30, 2024. Over the past year, it has dropped by -$32.00 thousand (-27.59%). APVO quarterly D&A is now -93.41% below its all-time high of $1.27 million, reached on September 30, 2017.APVO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APVO TTM D&A
$397.00 K
-$39.00 K-8.94%
30 September 2024
Summary:
As of January 23, 2025, APVO TTM depreciation & amortization is $397.00 thousand, with the most recent change of -$39.00 thousand (-8.94%) on September 30, 2024. Over the past year, it has dropped by -$170.00 thousand (-29.98%). APVO TTM D&A is now -89.33% below its all-time high of $3.72 million, reached on September 30, 2016.APVO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APVO Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.1% | -27.6% | -30.0% |
| 3 y3 years | -59.7% | -27.6% | -30.0% |
| 5 y5 years | -76.3% | -84.2% | -82.2% |
APVO Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.4% | at low | -69.6% | at low | -65.3% | at low |
| 5 y | 5-year | -74.6% | at low | -84.2% | at low | -82.2% | at low |
| alltime | all time | -83.1% | at low | -93.4% | at low | -89.3% | at low |
Aptevo Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $84.00 K(-7.7%) | $397.00 K(-8.9%) |
| June 2024 | - | $91.00 K(-14.2%) | $436.00 K(-11.9%) |
| Mar 2024 | - | $106.00 K(-8.6%) | $495.00 K(-12.7%) |
| Dec 2023 | $567.00 K(-37.1%) | $116.00 K(-5.7%) | $567.00 K(-7.4%) |
| Sept 2023 | - | $123.00 K(-18.0%) | $612.00 K(-13.9%) |
| June 2023 | - | $150.00 K(-15.7%) | $711.00 K(-15.1%) |
| Mar 2023 | - | $178.00 K(+10.6%) | $837.00 K(-7.1%) |
| Dec 2022 | $901.00 K(-21.2%) | $161.00 K(-27.5%) | $901.00 K(-9.5%) |
| Sept 2022 | - | $222.00 K(-19.6%) | $996.00 K(-6.8%) |
| June 2022 | - | $276.00 K(+14.0%) | $1.07 M(-2.1%) |
| Mar 2022 | - | $242.00 K(-5.5%) | $1.09 M(-4.5%) |
| Dec 2021 | $1.14 M(-18.6%) | $256.00 K(-13.2%) | $1.14 M(-7.0%) |
| Sept 2021 | - | $295.00 K(-1.3%) | $1.23 M(-0.4%) |
| June 2021 | - | $299.00 K(+1.7%) | $1.24 M(-0.8%) |
| Mar 2021 | - | $294.00 K(-14.0%) | $1.25 M(-11.5%) |
| Dec 2020 | $1.41 M(-37.1%) | $342.00 K(+14.0%) | $1.41 M(-12.0%) |
| Sept 2020 | - | $300.00 K(-2.9%) | $1.60 M(-13.3%) |
| June 2020 | - | $309.00 K(-32.1%) | $1.84 M(-12.5%) |
| Mar 2020 | - | $455.00 K(-14.6%) | $2.11 M(-5.7%) |
| Dec 2019 | $2.23 M | $533.00 K(-2.4%) | $2.23 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $546.00 K(-4.7%) | $2.31 M(-2.2%) |
| June 2019 | - | $573.00 K(-1.7%) | $2.36 M(-1.1%) |
| Mar 2019 | - | $583.00 K(-3.8%) | $2.39 M(-0.2%) |
| Dec 2018 | $2.39 M(-23.6%) | $606.00 K(+1.5%) | $2.39 M(+24.5%) |
| Sept 2018 | - | $597.00 K(-0.5%) | $1.92 M(-26.1%) |
| June 2018 | - | $600.00 K(+2.2%) | $2.60 M(-9.6%) |
| Mar 2018 | - | $587.00 K(+331.6%) | $2.87 M(-8.1%) |
| Dec 2017 | $3.13 M(-7.0%) | $136.00 K(-89.3%) | $3.13 M(-9.1%) |
| Sept 2017 | - | $1.27 M(+45.7%) | $3.44 M(+2.4%) |
| June 2017 | - | $875.00 K(+4.0%) | $3.36 M(-0.2%) |
| Mar 2017 | - | $841.00 K(+86.9%) | $3.37 M(+0.1%) |
| Dec 2016 | $3.36 M(+15.7%) | $450.00 K(-62.3%) | $3.36 M(-9.6%) |
| Sept 2016 | - | $1.20 M(+35.6%) | $3.72 M(+12.2%) |
| June 2016 | - | $881.00 K(+5.4%) | $3.32 M(+5.2%) |
| Mar 2016 | - | $836.00 K(+3.5%) | $3.15 M(+8.5%) |
| Dec 2015 | $2.91 M(+43.8%) | $808.00 K(+2.1%) | $2.91 M(+38.5%) |
| Sept 2015 | - | $791.00 K(+10.2%) | $2.10 M(+60.5%) |
| June 2015 | - | $718.00 K(+21.7%) | $1.31 M(+121.7%) |
| Mar 2015 | - | $590.00 K | $590.00 K |
| Dec 2014 | $2.02 M(+203.5%) | - | - |
| Dec 2013 | $666.00 K | - | - |
FAQ
- What is Aptevo Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual D&A year-on-year change?
- What is Aptevo Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly D&A year-on-year change?
- What is Aptevo Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM D&A year-on-year change?
What is Aptevo Therapeutics annual depreciation & amortization?
The current annual D&A of APVO is $567.00 K
What is the all time high annual D&A for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual depreciation & amortization is $3.36 M
What is Aptevo Therapeutics annual D&A year-on-year change?
Over the past year, APVO annual depreciation & amortization has changed by -$334.00 K (-37.07%)
What is Aptevo Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of APVO is $84.00 K
What is the all time high quarterly D&A for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly depreciation & amortization is $1.27 M
What is Aptevo Therapeutics quarterly D&A year-on-year change?
Over the past year, APVO quarterly depreciation & amortization has changed by -$32.00 K (-27.59%)
What is Aptevo Therapeutics TTM depreciation & amortization?
The current TTM D&A of APVO is $397.00 K
What is the all time high TTM D&A for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM depreciation & amortization is $3.72 M
What is Aptevo Therapeutics TTM D&A year-on-year change?
Over the past year, APVO TTM depreciation & amortization has changed by -$170.00 K (-29.98%)